Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by mercedesmanon Sep 13, 2023 8:11am
184 Views
Post# 35633287

Great Press Release !

Great Press Release !

The first time in my recollection that Spectral has so publicly acknowledged, on WorldSepsis Day, their commitment to finding a new and innovative solution. 

Also like the coining of ( emphasis on) Endotoxemic Septic Shock ( ESS) in the video " the most malignant form of septic shock
This is an important clarification as it better defines, to the medical community and investors alike, the target market. Much like 
the developers of a cancer cure would define the specific type of cancer they hope to cure with a new drug. 

This makes me wonder if Perhaps they do intend to make an investor splash in advance of the coming FDA decision, featuring Spectral itself, prior to the logical endgame? If so, this could mark an important milestone for investors. 

MM  

 

<< Previous
Bullboard Posts
Next >>